Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Has the Gestational Diabetes Market Grown from 2024 to 2025?

In recent times, there has been a robust expansion in the market size of gestational diabetes. The market is projected to escalate from $8.37 billion in 2024 to $9.14 billion in 2025, showing a compound annual growth rate (CAGR) of 9.3%. Various factors like a growing risk of diabetes, better precision in the measurement of blood glucose levels, an increased count of insurance providers, a rise in the number of diabetic patients and an overall surge in the diabetic population have contributed to the historic period growth.

What Growth Rate Is Anticipated for the Gestational Diabetes Market in the Coming Years?

Expectations are high for robust expansion in the gestational diabetes market over the coming years. By 2029, the market is forecasted to proliferate to $12.90 billion, boasting a compound annual growth rate (CAGR) of 9.0%. This anticipated growth trajectory during the prediction period can be credited to several factors, such as the escalating prevalence of obesity, growing adoption of cloud-based project setups, expanding use of relevant devices and applications, the rising instances of diabetes due to poor lifestyle choices, heightened public health awareness, and increasing diabetes prevalence rates. The prediction period is also expected to see significant trends including digital apps for managing diabetes, closed-loop control systems, diabetes management technologies, enzymatic technologies, and groundbreaking medical technologies.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20818&type=smp

Who Are the Leading Companies in the Gestational Diabetes Market?

Major companies operating in the gestational diabetes market are Sanofi S.A., AstraZeneca plc, Abbott Laboratories, Eli Lilly and Company, Novo Nordisk A/S, Becton, Dickinson and Company, Boehringer Ingelheim GmbH, Dexcom Inc, Biocon Limited, LifeScan Inc, Ascensia Diabetes Care Holdings AG, Trividia Health Inc., Nipro Diagnostics, Inc., Sernova Corp., ZyVersa Therapeutics, Inc., Peptron Inc., Roche Diabetes Care, DiabetOmics Inc, Merck & Co. Inc., Medtronic plc

What Are the Key Drivers of the Gestational Diabetes Market?

The expanding population experiencing obesity is seen as a significant driver for the growth of the gestational diabetes market. These individuals, with their Body Mass Index (BMI) hitting 30 or more, have excessive body fat, potentially leading to severe health issues. The causes for this obesity spike are inactive lifestyles, a higher intake of processed, high-calorie food, genetic predispositions, and restricted access to healthier food and exercise options. Those suffering from obesity are more at risk for gestational diabetes as their higher probability of insulin resistance and extreme weight gain during pregnancy could affect the mother and the child if not handled timely. Concretely, in March 2024, the World Health Organization, a Switzerland-based intergovernmental organization, stated that about one in eight people globally were considered obese in 2022, including 2.5 billion adults aged 18 and above, with 890 million of them classified as obese. Around 43% of adults were overweight and 16% were obese. Furthermore, 37 million children under the age of 5 were overweight, and over 390 million children and adolescents aged between 5-19 years were overweight, which included 160 million who were obese. Thus, the burgeoning obesity epidemic is fuelling the growth of the gestational diabetes market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=20818&type=smp

What Are the Key Market Segments in the Gestational Diabetes Industry?

The gestational diabetes market covered in this report is segmented –

1) By Types: Type A1, Type A2, Other Types

2) By Treatment: Monitoring, Drug Treatment, Non-pharmacological treatment

3) By Administration: Oral, Intravenous, Other Administrations

4) By End User: Hospitals, Clinics, Home Care Settings, Diagnostic Centers

Subsegments:

1) By Type A1: Diet-Controlled Gestational Diabetes, Exercise-Controlled Gestational Diabetes

2) By Type A2: Insulin-Controlled Gestational Diabetes, Oral Medication-Controlled Gestational Diabetes

3) By Other Types: Pre-Gestational Diabetes, Gestational Diabetes With Complications

What Are the Latest Trends in the Gestational Diabetes Market?

Leading firms in the gestational diabetes market are prioritizing the advancement of technology in their products. Their focus is mainly on diagnostic kits for gestational diabetes, aimed at providing swift, precise, and accessible solutions for early detection. These kits are essential medical tools used to examine blood glucose concentrations and detect irregular glucose tolerance in expectant mothers, contributing to the premature identification and management of the disease. In August 2024, for instance, DirectSens GmbH, a biotechnology firm based in Austria, introduced the XpressGT RUO kit. This diagnostic kit is engineered to detect gestational diabetes, endometriosis, insulin resistance, and liver disease by accurately gauging the levels of 2-hydroxybutyrate (2-HB) in venous blood. This chemical is naturally produced by the liver during regular activities. High 2-HB levels signify increased reductive stress, which is correlated to various endocrine and obesity-related ailments, including insulin resistance. This kit is adaptable to any existing clinical analyzer, providing results within just 8 minutes for a speedy and effective diagnostic approach.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/gestational-diabetes-global-market-report

What Are the Key Regional Markets in the Gestational Diabetes Industry?

North America was the largest region in the gestational diabetes market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gestational diabetes market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20818

This Report Delivers Insight On:

1. How big is the gestational diabetes market, and how is it changing globally?

2. Who are the major companies in the gestational diabetes market, and how are they performing?

3. What are the key opportunities and risks in the gestational diabetes market right now?

4. Which products or customer segments are growing the most in the gestational diabetes market?

5. What factors are helping or slowing down the growth of the gestational diabetes market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model